PeptiDream Inc.
JPX: 4587.T0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Tokyo Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Patrick Crawford Reid
- Employees
- 621
- Headquarters
- Kawasaki, Japan
- IPO year
- 2013
- Market cap
- ¥148.1B
- Website
- https://www.peptidream.com
Loading 4587…
Loading profile data…Frequently asked questions about 4587
What does PeptiDream Inc. (4587.T) do?
PeptiDream Inc., a biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics. The company develops its products based on its Peptide Discovery Platform System, a drug finding platform for the development of peptides. It has a collaborative research and ex...
Where does 4587.T trade?
PeptiDream Inc. (4587.T) trades on the Tokyo Stock Exchange.
What sector is 4587.T in?
PeptiDream Inc. (4587.T) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of PeptiDream Inc.?
Patrick Crawford Reid is the chief executive officer of PeptiDream Inc. (4587.T).
Where is PeptiDream Inc. headquartered?
PeptiDream Inc. is headquartered in Japan.
Does 4587.T pay a dividend?
PeptiDream Inc. (4587.T) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 4587.T go public?
PeptiDream Inc. (4587.T) completed its initial public offering in 2013.